Showing results (31-40 of 37) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
ACS Applied Materials & Interfaces|September 15, 2023
Discovery and Feasibility Study of Medical Fluorophore 33 as a Novel Theranostic AgentKwang Hee Son, Da Sol Lee, Geumi Park, et al.Medcomm|January 20, 2026
Inhibition of FOS-Like Antigen 1 Reduces Chemoresistance to Temozolomide Through Stemness Reprogramming via IL-6/STAT3Tyr705 PathwayJeongMin Sim, JeongMan Park, JinHyung Heo, et al.Journal of Medicinal Chemistry|January 6, 2025
Synthesis and Biological Evaluation of Peripheral HTR2A Antagonists for Colorectal CancerMinhee Kim, Jihyeon Yoon, Jun Young Choi, et al.European Journal of Medicinal Chemistry|August 8, 2020
An orally available inverse agonist of estrogen-related receptor gamma showed expanded efficacy for the radioiodine therapy of poorly differentiated thyroid cancerJina Kim, Hayoung Hwang, Heeseok Yoon, et al.Pharmaceutics|October 29, 2025
Design, Synthesis and Biological Evaluation of Pyrazolopyrimidine Derivatives as Aryl Hydrocarbon Receptor Antagonists for Colorectal Cancer ImmunotherapyByeong Wook Choi, Jae-Eon Lee, Da Bin Jeon, et al.Journal of Medicinal Chemistry|January 19, 2019
Discovery of Potent, Selective, and Orally Bioavailable Estrogen-Related Receptor-γ Inverse Agonists To Restore the Sodium Iodide Symporter Function in Anaplastic Thyroid CancerJina Kim, Jaeyoung Song, Hyun Dong Ji, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 24, 2019
A Novel Orally Active Inverse Agonist of Estrogen-related Receptor Gamma (ERRγ), DN200434, A Booster of NIS in Anaplastic Thyroid CancerThoudam Debraj Singh, Jaeyoung Song, Jina Kim, et al.Pageof 4